New pill tested to fight advanced cancers

NCT ID NCT03519178

Terminated Disease control Sponsor: Pfizer Source: ClinicalTrials.gov ↗

Summary

This study tested a new oral drug, PF-06873600, to see if it was safe and could help control advanced cancers. It involved 155 people with specific types of advanced breast cancer or ovarian cancer that had spread or stopped responding to other treatments. The drug was tested by itself and in combination with standard hormone therapies to find the right dose and see if it could shrink tumors.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HR+ HER2- METASTATIC BREAST CANCER, OVARIAN CANCER, FALLOPIAN TUBE CANCER, PRIMARY PERITONEAL CANCER, TRIPLE NEGATIVE BREAST CANCER, MALE BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

BIH of Omsk Region "Clinical Oncological Dispensary"

Omsk, 644013, Russia
BIH of Omsk Region "Clinical Oncological Dispensary"

Omsk, 644046, Russia
Brigham & Women's Hospital

Boston, Massachusetts, 02115, United States
Communal noncommercial enterprise of Lviv regional council "Lviv oncological regional therapeutical

Lviv, 79031, Ukraine
Communal nonprofit enterprise "Kyiv City Clinical Oncology Center" of Executive Body of Kyiv City

Kyiv, 03115, Ukraine
Complex Oncology Center -Plovdiv

Plovdiv, 4000, Bulgaria
Dana Farber Cancer Institute

Boston, Massachusetts, 02215, United States
Dana-Farber Cancer Institute

Boston, Massachusetts, 02215, United States
Fred Hutchinson Cancer Center

Seattle, Washington, 98109, United States
Highlands Oncology

Springdale, Arkansas, 72762, United States
Highlands Oncology Group

Fayetteville, Arkansas, 72703, United States
Highlands Oncology Group

Rogers, Arkansas, 72758, United States
Highlands Oncology Group

Springdale, Arkansas, 72762, United States
Holy Cross Hospital

Fort Lauderdale, Florida, 33308, United States
HonorHealth

Scottsdale, Arizona, 85258, United States
Kanagawa cancer center

Yokohama, Kanagawa, 2418515, Japan
Kharkiv Regional Specialized Dispensary of Radiation Protection of the Population

Kharkiv, Kharkivs’ka Oblast’, 61166, Ukraine
LLC "Medicina Severnoy Stolitsy"

Saint Petersburg, 191025, Russia
LLC "Severo-Zapadny Medical Center"

Saint Petersburg, 192007, Russia
Massachusetts General Hospital

Boston, Massachusetts, 02114, United States
McGill University Health Centre

Montreal, Quebec, H4A 3J1, Canada
Memorial Sloan Kettering Cancer Center

Long Island City, New York, 11101, United States
Memorial Sloan Kettering Cancer Center

New York, New York, 10065, United States
Multiprofile Hospital of Active Treatment - Dobrich AD

Dobrich, 9300, Bulgaria
Municipal Non-profit Enterprise "City Clinical Hospital #4" of Dnipro City Council, "Dnipro State Me

Dnipro, Dnipropetrovsk Oblast, 49102, Ukraine
National Cancer Center Hospital East

Kashiwa, Chiba, 277-8577, Japan
Northwest Medical Specialties, PLLC

Federal Way, Washington, 98003, United States
Northwest Medical Specialties, PLLC

Gig Harbor, Washington, 98332, United States
Northwest Medical Specialties, PLLC

Tacoma, Washington, 98405, United States
Private Medical Institution "Euromedservice"

Pushkin, Sankt-Peterburg, 196603, Russia
Rainier Hematology-Oncology PC

Puyallup, Washington, 98373, United States
Rainier Hematology-Oncology, PC

Puyallup, Washington, 98373, United States
South Texas Accelerated Research Therapeutics, LLC

San Antonio, Texas, 78229, United States
Specialized Hospital for Active Treatment of Oncology - Haskovo EOOD

Haskovo, 6300, Bulgaria
Tennessee Oncology, PLLC

Nashville, Tennessee, 37203, United States
The Oncology Institute of Hope and Innovation

Glendale, California, 91204, United States
The Oncology Institute of Hope and Innovation

Long Beach, California, 90805, United States
The Oncology Institute of Hope and Innovation

Santa Ana, California, 92705, United States
The Oncology Institute of Hope and Innovation

Whittier, California, 90602, United States
The Sarah Cannon Research Institute

Nashville, Tennessee, 37203, United States
The Sarah Cannon Research Institute-Pharmacy

Nashville, Tennessee, 37203, United States
The University of Texas MD Anderson Cancer Center

Houston, Texas, 77030, United States
UCHealth Lone Tree Medical Center

Lone Tree, Colorado, 80124, United States
UCLA Hematology/Oncology - Parkside

Santa Monica, California, 90404, United States
UCLA Hematology/Oncology - Santa Monica

Santa Monica, California, 90404, United States
UCSF Helen Diller Family Comprehensive Cancer Center

San Francisco, California, 94143, United States
UCSF Investigational Drugs Pharmacy

San Francisco, California, 94158, United States
University Of Alabama at Birmingham

Birmingham, Alabama, 35249, United States
University of Alabama at Birmingham

Birmingham, Alabama, 35233, United States
University of Colorado Hospital - Anschutz Cancer Pavilion (ACP)

Aurora, Colorado, 80045, United States
University of Colorado Hospital - Anschutz Inpatient Pavilion (AIP)

Aurora, Colorado, 80045, United States
University of Colorado Hospital - Anschutz Outpatient Pavilion (AOP)

Aurora, Colorado, 80045, United States
University of Washington Medical Center

Seattle, Washington, 98195, United States
Virginia G. Piper Cancer Center Pharmacy

Scottsdale, Arizona, 85258, United States

Conditions

Explore the condition pages connected to this study.

HR+ HER2- METASTATIC BREAST CANCER, OVARIAN CANCER, FALLOPIAN TUBE CANCER, PRIMARY PERITONEAL CANCER, TRIPLE NEGATIVE BREAST CANCER, MALE BREAST CANCER